Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1201 to 1250 of 2489

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribingNG114
Post-traumatic stress disorderNG116
Decitabine for untreated acute myeloid leukaemia (terminated appraisal)TA548
Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal)TA549
Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic painIPG632
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventionsIPG633
Tofacitinib for moderately to severely active ulcerative colitisTA547
Urinary tract infection (catheter-associated): antimicrobial prescribingNG113
Padeliporfin for untreated localised prostate cancerTA546
Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosisIPG631
Gemtuzumab ozogamicin for untreated acute myeloid leukaemiaTA545
Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinomaIPG630
Urinary tract infection (lower): antimicrobial prescribingNG109
Prostatitis (acute): antimicrobial prescribingNG110
Pyelonephritis (acute): antimicrobial prescribingNG111
Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and childrenMIB163
Romiplostim for the treatment of chronic immune thrombocytopeniaTA221
Eltrombopag for treating chronic immune thrombocytopeniaTA293
Myeloma: diagnosis and managementNG35
Lyme diseaseNG95
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanomaTA544
Renal replacement therapy and conservative managementNG107
Decision-making and mental capacityNG108
Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA543
Cabozantinib for untreated advanced renal cell carcinomaTA542
Renal replacement therapy services for adultsQS72
myAIRVO2 for the treatment of chronic obstructive pulmonary diseaseMIB161
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aortaMTG16
OxyMask for delivering oxygen therapyMIB160
Eating disordersQS175
AsthmaQS25
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancerIPG628
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemiaTA541
The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needsMIB159
Chronic heart failure in adults: diagnosis and managementNG106
Preventing suicide in community and custodial settingsNG105
Emergency and acute medical care in over 16sQS174
Leadless cardiac pacemaker implantation for bradyarrhythmiasIPG626
Superior rectal artery embolisation for haemorrhoidsIPG627
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Neon EEG electrode for EEG monitoring in newbornsMIB155
AlignRT in breast cancer radiotherapyMIB157
Sutureless aortic valve replacement for aortic stenosisIPG624
Flu vaccination: increasing uptakeNG103
Dinutuximab beta for treating neuroblastomaTA538
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG625
Intermediate care including reablementQS173
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537

Results per page

  1. 10
  2. 25
  3. 50
  4. All